Back to search

Article

Preventing large deletions and chromosome loss in engineered human primary T cells by CasPlus with optimized guide RNAs

2025-01-31

Abstract excerpt

Genetically engineered T-cell therapies rely heavily on genome editing tools, such as the CRISPR/Cas9 system. However, unintended on-target chromosomal alterations, including large deletions and chromosome loss can occur and pose significant risks including tumorigenesis. Here we combined CasPlus and optimized guide RNAs to reduce these issues in CRISPR/Cas9 engineering human primary T cells. CasPlus, which integr...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
babc33c8-5685-5184-bd13-42fe0434f1f6
DOI
10.1101/2025.01.29.635575
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preventing large deletions and chromosome loss in engineered human primary T cells by CasPlus with optimized guide RNAsDOI 10.1101/2025.01.29.635575
Select a neighboring publication to make it the new centre.